Adolescent use of the monthly contraceptive injection

Journal of Pediatric and Adolescent Gynecology

Volumn 18, Issue 4, 2005, Pages 255-260

  Tuchman, Lisa Kessler ^a,b   Huppert, Jill S ^c   Huang, Bin ^c   Slap, Gail B ^c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Adherence; Adolescent; Contraception; Overweight; Weight

Indexed keywords

CONTRACEPTIVE AGENT; DESOGESTREL; DROSPIRENONE; ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORGESTREL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADOLESCENT; ADULT; BLEEDING; BODY MASS; BODY WEIGHT; CAUCASIAN; CONTRACEPTION; DEMOGRAPHY; FEMALE; HUMAN; MEDICAL RECORD; OBESITY; PREGNANCY; PRIORITY JOURNAL; RANK SUM TEST; REVIEW; SCHOOL CHILD; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; WEIGHT GAIN;

EID: 24944584699     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpag.2005.05.004     Document Type: Article

References (22)

1. Food and Drug Administration MEDWATCH. 2002 Safety Alert - Norplant (levonorgestrel implants). Important Norplant® System (levonorgestrel implants) Update: Back-up Contraception No Longer Required on Specified Lots. http://www.fda.gov/medwatch/SAFETY/2002/norplant.htm July 26, 2002
2. A. Bonny, K. Camlin, and R. Harvey Prospective analysis of weight changes in adolescent females inititating depomedroxyprogesterone acetate (DMPA), oral contraceptive pills (OC), or no hormonal contraceptive method J Adolesc Health 32 2 2003 134
3. B.A. Cromer Recent clinical issues related to the use of depot medroxyprogesterone acetate (Depo-Provera) Curr Opin Obstet Gynecol 11 1999 467
4. C. O'Dell, C.M. Forke, and M.M. Polaneczky Depot med- roxyprogesterone acetate or oral contraception in post- partum adolescents Obstet Gynecol 91 1998 609
5. M. Polaneczky, M. Guarnaccia, and J. Alon Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population Fam Plann Perspect 28 1996 174
6. M.M. Stager, and B.A. Cromer Management of clinical side effects of DMPA J Pediatr Adolesc Gynecol 13 2000 147
7. R.J. Garceau, C.J. Wajszczuk, and A.M. Kaunitz Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives Contraception 62 2000 289
8. A.M. Kaunitz Current options for injectable contraception in the United States Semin Reprod Med 19 2001 331 Review
9. O.P. Phillips New aspects of injectable contraception Int J Fertil Womens Med 46 2001 31 Review
10. L.P. Shulman Expanding contraceptive choices: Lunelle monthly contraceptive injection Int J Fertil Womens Med 45 2000 190 Review
11. P.E. Hall New once-a-month injectable contraceptives, with particular reference to Cyclofem/Cyclo-Provera Int J Gynaecol Obstet 62 Suppl 1 1998 S43
12. A.M. Kaunitz, R.J. Garceau, and M.A. Cromie Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lunelle Study Group Contraception 60 1999 179
13. L.P. Shulman Controlled trial with a monthly combination injectable contraceptive in the USA Gynecol Endocrinol 15 Suppl 3 2001 S15
14. National Center for Health Statistics: National Health and Nutrition Examination Surveys: Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/nhanes. html ; 2000
15. National Center for Health Statistics: CDC Growth Charts: United States. http://www.cdc.gov/growthcharts/ 2000
16. C. Kramer Extension of multiple range tests to group means with unequal numbers of replications Biometrics 12 1956 307
17. D.W. Hosmer Jr., and S. Lemeshow Descriptive methods for survival data Applied Survival Analysis: Regression Modeling of Time To Event Data 1999 John Wiley & Sons New York NY 27 86
18. J.M. Foidart Acomparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel Eur J Contracept Reprod Health Care 5 2000 124
19. W. Kidson Polycystic ovary syndrome: A new direction in treatment Med J Aust 169 1998 537
20. R.S. Legro Polycystic ovary syndrome: Long term sequelae and management Minerva Ginecol 54 2002 97
21. W.C. Tan, C. Yap, and A.S. Tan Clinical management of PCOS Acta Obstet Gynecol Scand 80 2001 689
22. A.R. Davis, and S.B. Teal Controversies in adolescent hormonal contraception Obstet Gynecol Clin N Am 30 2003 391